Rianlon Valuation Multiples
Rianlon is valued at $1.4B as of November 2026, a 1.7x revenue multiple. In the last 12 months, Rianlon revenue was $1B and Rianlon EBITDA was $174M.
Rianlon Overview
About Rianlon
Rianlon Corp provides polymer additives and solutions for the polymer materials industry. Its product portfolio consists of General Antioxidants, Specialty Antioxidants, UV-Absorbers, Hindered Amine Light Stabilizers, and Blend Addtives.
Founded
2011
HQ
Employees
N/A
Website
Financials (LTM)
EV
$1.7B
Valuation Multiples
Start free trial
Rianlon Financials
Rianlon reported last 12-month revenue of $1B and EBITDA of $174M.
In the same LTM period, Rianlon generated $236M in gross profit, $174M in EBITDA, and $91M in net income.
Revenue (LTM)
Rianlon P&L
In the most recent fiscal year, Rianlon reported revenue of $904M and EBITDA of $146M.
Rianlon is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 16%, and net margin of 8%.
Financial data powered by Morningstar, Inc.
Rianlon Stock Performance
Rianlon has current market cap of $1.4B, and enterprise value of $1.7B.
Market Cap Evolution
Rianlon's stock price is $6.06.
Rianlon share price increased by 5.2% in the last 30 days, and by 8.4% in the last year.
Rianlon has an EPS (earnings per share) of $0.32.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.7B | $1.4B | -1.1% | 5.2% | -2.5% | 8.4% | $0.32 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialRianlon Valuation Multiples
Rianlon trades at 1.7x EV/Revenue multiple, and 9.9x EV/EBITDA.
EV / Revenue (LTM)
Rianlon Financial Valuation Multiples
As of November 7, 2026, Rianlon has market cap of $1.4B and EV of $1.7B.
Rianlon has a P/E ratio of 15.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Rianlon Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Rianlon Margins & Growth Rates
Rianlon grew revenue by 13% and EBITDA by 23% in the last fiscal year.
In the most recent fiscal year, Rianlon reported gross margin of 22%, EBITDA margin of 16%, and net margin of 8%.
Rianlon Margins
Rianlon Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Rianlon Operational KPIs
Rianlon's Rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Rianlon's Rule of X is 50% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Rianlon Competitors
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
This data is available for Pro users. Sign up to see all Rianlon competitors and their valuation data. Start Free Trial | ||||||
Investments by Rianlon
Rianlon has invested in 3 companies to date.
Latest investment by Rianlon was on May 10th 2026. Rianlon invested in Plastic New Technology in their Series A round.
Latest Investments by Rianlon
![](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="20" height="20" viewBox="0 0 20 20"><rect fill="%23e5e7eb" width="20" height="20" rx="4"/></svg>){kind=small} Heng Hai Kai Wu | |||
| Description | Plastic New Technology centers on enzymatic depolymerization and recycling of post-consumer waste polyester textiles and other polymeric materials. | Heng Hai Kai Wu is a biomanufacturing company leveraging proprietary in vitro biotransformation technology to produce food ingredients, health products, novel chemical materials, and enzyme preparations. | Yuantian Bio is a biotechnology company based in China specializing in enzymatic regeneration technologies and commercial applications for recycled plastic PET. It produces over ten low-cost enzyme preparations through fermentation and supports large-scale biochemical product manufacturing for industrial clients. |
| HQ Country | | | |
| HQ City | Beijing | - | Tianjin |
| Deal Date | 10 May 2026 | 15 Jan 2026 | 16 Apr 2025 |
| Round | Series A | Seed | Seed |
| Raised | undisclosed | undisclosed | $14M |
| Investors | Innoangel Fund; Fu Yuan Investment; Haitang Fund; Shangshi Fund; Tianjin Renai Capital; Rianlon | Haitang Fund; Shangshi Fund; Rianlon; Renai Jiasheng | Dalton Venture; Haitang Fund; Shangshi Fund; Tianjin Renai Capital; Rianlon |
| Valuation | undisclosed | undisclosed | undisclosed |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Rianlon investments and their VC round multiples. Start Free Trial | |||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Rianlon
| When was Rianlon founded? | Rianlon was founded in 2011. |
| Where is Rianlon headquartered? | Rianlon is headquartered in China. |
| Is Rianlon publicly listed? | Yes, Rianlon is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Rianlon? | Rianlon trades under 300596 ticker. |
| When did Rianlon go public? | Rianlon went public in 2017. |
| Who are competitors of Rianlon? | Rianlon main competitors include |
| What is the current market cap of Rianlon? | Rianlon's current market cap is $1.4B. |
| What is the current revenue of Rianlon? | Rianlon's last 12 months revenue is $1B. |
| What is the current revenue growth of Rianlon? | Rianlon revenue growth (NTM/LTM) is 13%. |
| What is the current EV/Revenue multiple of Rianlon? | Current revenue multiple of Rianlon is 1.7x. |
| What is the current EBITDA of Rianlon? | Rianlon's last 12 months EBITDA is $174M. |
| What is Rianlon's EBITDA margin? | Rianlon's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of Rianlon? | Current EBITDA multiple of Rianlon is 9.9x. |
| How many companies Rianlon has acquired to date? | Rianlon hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Rianlon has invested to date? | As of November 2026, Rianlon has invested in 3 companies. |
| What was the last Rianlon investment? | On 10th May 2026 Rianlon invested in Plastic New Technology, participating in a Series A round, alongside Innoangel Fund, Fu Yuan Investment, Haitang Fund, Shangshi Fund, and Tianjin Renai Capital. |
| In what companies Rianlon invested in? | Rianlon invested in Yuantian Bio, Heng Hai Kai Wu, and Plastic New Technology. |
Lists including Rianlon
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.